Biorigin buys Immunocorp Animal Health
The Brazilian company Biorigin has bought Immunocorp Animal Health AS, a subsidiary of
the Norwegian pharmaceuticals developer Biotec Pharmacon ASA. The sales consideration amounts to
As a part of the present sale there will be established a collaboration
agreement between the selling company Biotec Pharmacon and Immunocorp Animal
Health that will ensure technology transfer from Biotec to Biorigin for the
further refinement and development of the product. In Brazil Biorigin produces
immune stimulating glucans for the South-American market.
has bought Immunocorp to acquire the leading Norwegian competence and establish
a stronghold for growth in Europe. "This is the first step in
internationalization for Biorigin", says General Manager Mario Steinmetz of
Biorigin. "Our plan is to maintain Immunocorp Animal Health's existing
organization and employees in Norway, while using its structure and technical
knowledge to continue to support expansion of the position of Biorigin in
Immunocorp Animal Health
Health develops and markets immune stimulating products for aquaculture and
agriculture. Its brand MacroGard® is an ecological alternative to feed
antibiotics and chemotherapeutics for livestock, pets and cultured aquatic
organisms. MacroGard® is based on a well-characterized and scientifically proven
beta-1,3/1,6-glucan that has been in use world-wide for almost 15 years as an
immune modulating agent in animal husbandry and aquaculture. Immunocorp Animal
Health has a crew of seven persons and a total sale of NOK 14.1
(€1.78m) million during the first six months of 2008.
Founded in 2003 Brazilian Biorigin produces
yeast cell derivates for the food industry and animal nutrition. From the start
in 2003 Biorigin has seen a yearly growth of 30 p.c. Biorigin is part of the
Zilor Group, a leading producer of sugar, ethanol and bio energy.
Subscribe here to the free animal feed
To comment, register here
Or register to be able to comment.